Table 5.
Baseline characteristics of diabetic patients with COVID-19 on admission to hospital.
| All Patients (n = 150) | Noncritical COVID-19 (n = 108) | Critical COVID-19 (n = 42) | P value | |
|---|---|---|---|---|
| Ages | 64 (57-71) | 62 (55-70) | 69 (61-75) | 0.001 |
| Sex | ||||
| Female | 67 (44.7%) | 54 (50.0%) | 13 (31.0%) | 0.035 |
| Male | 83 (55.3%) | 54 (50.0%) | 29 (69.0%) | |
| Days from illness onset to admission | 10 (7-15) | 10 (7-20) | 10 (7-12) | 0.126 |
| Metformin | 34 (22.7%) | 33 (30.6%) | 1 (2.4%) | <0.001 |
| Neutrophils (×109 per L) | 4.16 (2.82-6.23) | 3.58 (2.63-5.14) | 6.83 (4.25-9.32) | <0.001 |
| Lymphocytes (×109 per L) | 0.97 (0.57-1.33) | 1.11 (0.76-1.51) | 0.62 (0.35-0.84) | <0.001 |
| Monocytes (×109 per L) | 0.36 (0.26-0.51) | 0.39 (0.29-0.53) | 0.33 (0.21-0.45) | 0.112 |
| Platelets (×109 per L) | 182 (128-245) | 193 (150-264) | 152 (103-204) | <0.001 |
| Total cholesterol (mmol/L) | 3.83 (3.20-4.66) | 3.96 (3.42-4.70) | 3.38 (2.92-4.57) | 0.02 |
| Triglyceride (mmol/L) | 1.42 (1.05-1.90) | 1.37 (1.05-1.87) | 1.58 (1.04-2.02) | 0.734 |
| High density lipoprotein cholesterol (mmol/L) | 0.92 (0.79-1.23) | 1.03 (0.84-1.27) | 0.85 (0.72-0.96) | 0.002 |
| Low density lipoprotein cholesterol(mmol/L) | 2.20 (1.69-2.78) | 2.22 (1.77-2.80) | 1.81 (1.44-2.56) | 0.062 |
| Neutrophil to high-density lipoprotein cholesterol ratio (NHR) | 4.16 (2.73-7.24) | 3.66 (2.44-5.07) | 8.64 (4.82-12.29) | <0.001 |
| Monocyte to high-density lipoprotein cholesterol ratio (MHR) | 0.38 (0.25-0.51) | 0.39 (0.25-0.51) | 0.38 (0.25-54) | 0.844 |
| Lymphocyte to high-density lipoprotein cholesterol ratio (LHR) | 0.96 (0.59-1.45) | 1.18 (0.73-1.60) | 0.73 (0.49-0.99) | <0.001 |
| Platelet to high-density lipoprotein cholesterol ratio (PHR) | 186.18 (129.06-262.53) | 187.25 (134.44-263.16) | 183.20 (113.79-252.57) | 0.451 |
Data are median (IQR) or n (%). P values comparing critical and noncritical COVID-19 are from χ² test and Mann-Whitney U test.